#USA #San Diego #Class Action #Securities Fraud #C3.ai

C3.AI Investor Alert: A Chance for Justice

C3.ai, Inc. (NYSE: AI) has found itself at the center of a significant class action lawsuit, sparking interest among investors who have faced considerable financial losses. The lawsuit, led by the Robbins Geller Rudman & Dowd LLP law firm, invites affected investors to step forward as potential lead plaintiffs in a suit that promises to address serious allegations against the company and its executives.

Overview of the Case

The lawsuit, officially known as Liggett v. C3.ai, Inc., filed in the Northern District of California under docket number 25-cv-07129, claims that C3.ai and several of its top executives have violated the Securities Exchange Act of 1934. The allegations suggest that the company intentionally misrepresented its revenue outlook and growth potential while downplaying risks related to the health of C3.ai's CEO, Thomas M. Siebel.

Robbins Geller asserts that C3.ai’s leaders led investors to believe in an overly optimistic view of its financial performance and growth trajectories. However, evidence presented in the lawsuit indicates that these claims were not substantiated, particularly in light of CEO Siebel's health issues, which supposedly impacted the company’s performance significantly.

Key Allegations

The lawsuit alleges that on August 8, 2025, C3.ai released disappointing preliminary financial results for the first quarter of its fiscal year 2026. Alongside this release, it reduced its revenue guidance for the entire fiscal year, attributing the downturn to “reorganization with new leadership” and the CEO's health problems. Following this news, C3.ai’s stock price plummeted by more than 25%, leaving many investors with substantial losses.

Investors who think they have suffered financial harm during the class period are encouraged to take action. To be eligible to serve as lead plaintiff, they must act swiftly, as motions for lead plaintiff must be submitted by October 21, 2025. This process allows the appointed lead plaintiff to represent the interest of all other class members in the lawsuit, directing the litigation while selecting a law firm to handle the case—potentially securing recovery for financial damages incurred.

The Importance of Being a Lead Plaintiff

Taking on the role of a lead plaintiff is not just an opportunity to seek personal recovery; it also grants the chosen individual a say in how the class action unfolds. Although the private securities litigation reform allows for appointment based solely on financial interest in the outcome, it also requires that the lead plaintiff be typical of the class they represent. This means they must share similar circumstances with fellow investors to effectively advocate on behalf of the group.

About Robbins Geller Rudman & Dowd LLP

The Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation. Ranking first in investor recovery among law firms, they have secured over $2.5 billion for clients in securities-related class action cases in 2024 alone. With 200 attorneys and ample resources at their disposal, Robbins Geller aims to bolster investor rights and accountability in corporate governance, as illustrated by their track record in high-profile cases like the Enron Corporation litigation.

Conclusion

Investors who have suffered losses due to the recent downturn at C3.ai have a significant opportunity to seek justice through this class action lawsuit. With allegations indicating that the company's executives may have provided misleading information, affected individuals are urged to consider their options carefully. In a landscape where the protection of investor interests is ever-important, class actions like this can be pivotal in seeking recovery and holding corporations accountable.

For more information or to discuss your potential participation in this class action lawsuit, investors can contact Robbins Geller attorneys J.C. Sanchez or Jennifer N. Caringal at 800-449-4900 or via email at [email protected].